Trial intelligence / Profile preview

Oxycodone versus sufentanil for general anesthesia in cerebral endovascular procedures

ChiCTR2500095589Phase 4Not yet recruiting

Sponsor
Henan Provincial People's Hospita,medical
Start
Jan 2025
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in cerebrovascular disease comparing Sufentanil group with Oxycodone group (2 arms). Primary endpoint: RASS score. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

oxycodonesufentanil
03

Conditions

cerebrovascular disease

Beyond the preview

Go deeper on ChiCTR2500095589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call